Suntec REIT Eyes Injection of 9 Penang Road from Sponsor Tang Organization — Eight-Storey Orchard/Dhoby Ghaut Commercial Asset a Potential Pipeline
Tang Organization, the new sponsor of Suntec Real Estate Investment Trust, may inject its 9 Penang Road building — which houses UBS's Singapore operations — into the Reit's portfolio.
Tang Organization, the new sponsor of Suntec Real Estate Investment Trust, may inject its 9 Penang Road building — which houses UBS's Singapore operations — into the Reit's portfolio. Suntec Trust Management was responding to a unitholder query ahead of the Reit's annual general meeting on Thursday (Apr 10), addressing Tang Organization's pipeline of properties for the Reit.
- ▸Location: Orchard Road / Dhoby Ghaut — prime commercial and retail hub
- ▸Description: Eight-storey Grade-A commercial building comprising two office towers and an ancillary retail space
- ▸Completed: 2019
- ▸Current occupancy: UBS Singapore operations
- ▸Ownership history: Suntec Reit sold its 30% stake in 2021 to Haiyi Holdings for ~S$89.9M. Haiyi Holdings had previously co-redeveloped the site with Suntec Reit and SingHaiyi Group, already holding a 35% JV stake prior to buying out Suntec Reit's interest. Tang Organization (Gordon Tang / Celine Tang) controls Acrophyte Asset Management, which took over as Suntec's manager (previously ESR Trust Management) in March 2026.
MANAGER'S POSITION
The Suntec Trust Management team said it will undertake a review to strengthen portfolio performance and enhance capital efficiency, including exploring disciplined approaches to asset-optimisation and recycling. Value-unlocking strategies cited by analysts include a potential acquisition of 9 Penang Road from Gordan Tang's SingHaiyi Group.
The Tangs also hold interests in One Raffles Quay (ORQ), Marina Bay Financial Centre (MBFC) Towers 1 and 2, and Marina Bay Link Mall. In December 2025, Hongkong Land announced plans to inject its ORQ and MBFC Towers 1 and 2 holdings into a new private fund, having offered JV partners pre-emptive rights to purchase stakes in ORQ and MBFC Towers 1, 2 and 3. Keppel Reit exercised its option to acquire Hongkong Land's one-third stake in MBFC Tower 3 for S$1.45B. Pre-emptive offers for ORQ and MBFC Towers 1 and 2 lapsed.
UNITHOLDER CONCERNS — MANAGER'S RESPONSES
- ▸On ORQ / MBFC: The manager said these are very good quality assets in the core CBD, priced competitively. Any acquisition funded fully by debt would bring aggregate leverage above 45% for a one-sixth stake — not viable at current structure.
- ▸On NAV discount: Reit was trading at ~30% discount to NAV. Discount narrowed to 29% as at Dec 31, 2025 (from 43% a year earlier). Issuing equity would be dilutive to NAV and DPU — manager's view: not in unitholders' interest.
Suntec Reit previously divested strata office floors at Suntec City. In 2021, three floors in Towers 1 and 2 were sold to SilkRoad Property Partners for S$197M — an 8.9% premium to independent valuation of S$180.9M, net gain S$13.9M. Those properties changed hands in 2024 when HSBC Asset Management took over SilkRoad; HSBC has listed them for sale at S$135M.
The 9 Penang Road injection is a live pipeline item but not imminent — the manager is running a strategic review first. The key question for unitholders: how aggressively will the Tang-affiliated management team pursue asset recycling, and can the sponsor's CBD holdings (ORQ, MBFC, 9 Penang Road) be injected on terms that are genuinely accretive given current leverage constraints? Units of Suntec Reit closed up 1.3% at S$1.52 on Wednesday.